Growth Strategy
Integrated Report 2023

26

CONTENTS

Prologue

Value
Creation

GrowthStrategy

CapitalStrategy

GrowthStrategy

Corporate
GovernanceCorporate
Data

27

Integrated Report 2023

Growth Strategy
CONTENTS

2030 Goals and Roadmap
based on the vision. In the business domains of medical care, nursing care, and health promotion, which are highly contributable
to society, we will transform our business model in response to changes in society and the times, while co-creating customer
value as a partner of them and contributing to society in which all people can enjoy lifelong health.

Value
Creation

Medium-term Management Plan
Accelerate speed of expansion
utilizing partnerships and CVC

April 2020 – March 2024

Phase II

April 2024 – March 2027

Focus points

1 Expansion of current businesses
2 Fully engaging in health promotion business
3 Establishing the foundations for change

1 Expansion of recurring revenue businesses
2 Advancement of health promotion business3 Leap forward in key areas of Asia

April 2027 – March 2030

Smiles for Everyone from
Medical and Nursing
Care to Health Field

Target for the ﬁnal year of Phase II

Net sales

120billion yen

Operating income

Medium-termManagement Plan

Corporate
Data

Address the SDGs and social contributions,as well as develop the human resource base and renew our core system

17billion yen

Corporate
Governance

Focus points

Phase III

Paramount Vision 2030

CapitalStrategy

Phase ITo be an indispensable company tosociety by creating new value

GrowthStrategy

Medium- to long-term investment
phase anticipating 10 years of growth

Corporate
Principles

Prologue

Our Group is promoting “Paramount Vision 2030,” which is to be realized by 2030, and the Medium-term Management Plan

28

Integrated Report 2023

Growth Strategy
CONTENTS

Progress in Phase I
2Fully engaging in healthpromotion business3

Establishing the foundations
for change

In order to reform our business model and to change our

COVID-19, high costs for materials and energy, shortages inpillar to join our medical care and nursing care businesses incorporate culture, we are working to improve our foundation,

the supply of semiconductors and other components, and thethe future, based primarily on our two brands of “INTIME”—

including improving our in-house system offerings andcontinuing situation in Ukraine, we set new record highs foran electric bed that can transform for nursing-care use—andworkplace environment. We are gradually expanding andboth sales and operating income for the third fiscal year in a

“Active Sleep BED”—an automatic electric bed utilizing sleep

improving our employee training system and career building

row. Recurring revenue business and “Nemuri SCAN” sales

sensors. Although sales increased by approximately 18%

support system, as well as promoting diversity and work styleremaining steady contributed to this. We will also be aiming tocompared to the previous year, we feel that awareness is stillreforms. This fiscal year, we will reorganize and revise ourfurther expand during the final year of Phase I.

low, and we will further strengthen its promotion.

core work system in order to further expand operations.

Operating income(Billions of yen)

Net sales(Billions of yen)
110

Phase I

Operating income
margin2021/32022/32023/3

82.3

87.1

90.3

99

2024/3
Forecast

105

billion yen

billion yen

billion yen

billion yen

billion yen

billion yen

billion yen

billion yen

billion yen

billion yen

9.9

12.0％

11.5

13.3％

12.3

13.7％

13.4

13.6％

14

13.3％

2024/3Resultsvs. previous year*

Resultsvs. previous year*

Forecast

vs. previous year*

14

Medicalcare business

34,230−37,291+8.9%

39,119+4.9%

11

Nursingcare business

52,317−57,521+9.9%

60,669+5.5%

8Health promotion
business

2,141

−

2,517

+17.5%

3,500+39.0%

Others

1,662

−

1,678

+1.5%

1,710

+1.9%

Total

90,352−99,009+9.6%

105,000+6.1%*Due to the “Accounting Standard for Revenue Recognition” (ASBJ Statement No. 29) being applied from the beginningof the ﬁscal year ended March 31, 2022, year-on-year changes in net sales are not listed here.

Corporate
Data

Operating income

2020/3

Unit: Millions of yen

2023/3

Corporate
Governance70

Net sales

2022/3

17

90

50

Net Sales by Business Segment

CapitalStrategy

Phase I Performance

GrowthStrategy

We intend to strengthen our service in order to create a third

Value
Creation

Although there were numerous unclear factors such as

Prologue

1 Expansion of current businesses

29Integrated Report 2023

Growth Strategy
CONTENTS

Direction and Focus Points for Phase II
Advancement of health2 promotion business

Leap forward in key areas
3 of Asia
We are focusing on areas such as China, Indonesia, andcare business, and packaged rentals of equipment and facilities,

health promotion business, as the third pillar of our Group

India where the population is large, the number of hospitaletc., and on-site services (equipment management, repair work,

along with medical and nursing care. A gradually expanding

beds is expected to increase, and an increased demand for

nursing assistant services, and concierge services) and othersleep market. We will also utilize the knowledge obtained withhigher-functioning equipment is anticipated. In India, we areservices in our medical care business, are our current recurring

corporate venture capital, and expand business that makes aplanning to begin operations of a new, large-scale factory inrevenue businesses. In the future, we will develop more newhigh contribution to society with the aim of extending healthy2024. We will increase our presence in these areas, and we aim

oﬀerings, and we plan to break away from the conventional

life expectancy.

to be the top medical bed manufacturer in Asia.

●Expand sleep improvement products●No. 1 share of medical beds in the countries of operations

expectancy●Expand services provided by partnering with othercompanies●Aim for CAGR 10% in sales

sellout-style sales.
●Accelerate expansion of current recurring revenue

The ratio of recurring revenue business to net sales in Japan
Medical care business6 billion yen

Nursing care business25.6 billion yen

5,000(Millions of yen)

Increased to

45

2,517

3,500

2024/3
Forecast(Millions of yen)

Increased to over5%
2023/3Results

Overseas net sales

2027/3
Target9,271

15,00010,800

Increased to15billion yen
2023/3Results

2024/3
Forecast

2027/3
TargetAiming for 120 billion yen in net sales and 17 billion yen in operating income in the ﬁnal year of Phase II

billion yen

Corporate
Data

35.3％

2027/3of beds sold

Corporate
Governance2023/3

Health promotion business net sales●Increase production capacity to support increase in number

CapitalStrategybusinesses● Develop new recurring revenue business offerings utilizing
sensing technology, AI, IoT, etc.

●Products and services contributing to extending healthy life

GrowthStrategy

We will work to strengthen products and services in our

Value
Creation

An assistive product rental wholesale business in our nursing

Prologue

Expansion of recurring
1 revenue businesses

30Integrated Report 2023

Growth Strategy
CONTENTS

Financial Strategy of the Medium-term Management Plan

Yosuke Kimura

respond to increased demand for promoting work stylereforms for medical and nursing staff, as well as the pricerevisions we enacted in October.

Our business results for the fiscal year ended March 31,

The final year of Phase I of the Medium-termManagement Plancare, nursing care, and health promotion businesses
despite a persistently difficult environment with highof Phase I of the Medium-term Management Plan. We

sales reached a high of 99,009 million yen (9.6% increase

have advocated three focus points for Phase I: “expansion

year on year), and after formulating the Medium-termof current businesses,” “fully engaging in health promotion

Management Plan, achieved new record highs for threebusiness,” and “establishing the foundations for change.”

consecutive years. With regard to profits, operating income

We have already achieved our performance targets for thewas 13,452 million yen (9.0% increase year on year),fiscal year ended March 31, 2022, two years earlier thanordinary income was 14,139 million yen (4.4% increase

scheduled, and we will explain our progress in terms of theyear on year), and net income attributable to owners of the

focus points here. In “expansion of current businesses,”parent was 9,215 million yen (1.3% increase year on year),sales of “Nemuri SCAN” and our “Smart Bed System™,”

setting new records for each. We have seen rewarding

as well as our recurring revenue business in the nursing

2021/32022/32023/32024/3vs. previous year

Resultsvs. previous year*

Resultsvs. previous year

Forecast

vs. previous year

Net sales

87,171+5.8％

90,352−99,009+9.6％

105,000+6.1％

Operating income

11,582+16.9％

12,340+6.5％

13,452+9.0％

14,000+4.1％

Ordinary income

13,461+32.7％

13,543+0.6％

14,139+4.4％

14,500+2.6％

Net income attributable to owners of the parent

8,611+22.3％

9,092

+5.6％

9,215

+1.3％

9,800

+6.3％

*Due to the “Accounting Standard for Revenue Recognition” (ASBJ Statement No. 29) being applied from the beginning of the ﬁscal year ended March 31, 2022, year-on-year changes in net sales are not listed here.

Corporate
Data

Results

Corporate
Governancethe supply of semiconductors and other components. Net

CapitalStrategyThis fiscal year ending on March 31, 2024 is the final year

GrowthStrategymaterial prices and logistics costs, along with shortages in

Value
Creation

2023 set new fiscal-year records in each of our medical

Unit: Millions of yen

Prologue

Senior Managing Director and CFO

results from our various measures, such as being able to

Setting new record highs in net sales andoperating income for three consecutive years

31

Integrated Report 2023

Growth Strategy

this plan will be 85 billion yen or more. Constantly taking

engaging in health promotion business,” our “INTIME

Next fiscal year we will begin Phase II. Based on theand in some instances plays a major role in putting on the3000” launched in September 2021 contributes to sales

strengthened foundation we built during Phase I, we

brakes and preventing fraud or other misconduct. We willthroughout the year. However, low awareness is still an

will utilize our partnerships with other companies and cor-

conduct thorough monitoring and risk control in order toissue. In “establishing the foundations for change,” weporate venture capital (CVC) in order to accelerate our ex-

appropriately support timely decision making.

are making efforts such as renewing our core system

pansion speed. We have three focus points of “expansion

With shareholder returns at 20 billion yen or more, we

and strengthening both our personnel development andof recurring revenue businesses,” “advancement of healthbelieve that it would be ideal if we could increase dividends

in-house systems. In particular, investment in our core

promotion business,” and “leap forward in key areas ofin a stable manner, targeting the dividend on equity ratio

system involves short-term pain due to the large scale,

Asia.” We aim to increase our ratio of recurring revenue(DOE) of 2.7% and a dividend payout ratio of 30%. In orderbut looking at the medium- and long-term perspective, itbusiness to net sales in Japan to reach 45%. Because weto ensure that all shareholders truly feel the growth of theis certain to improve overall efficiency. We will continue

are investing in the assets related to recurring revenue

Group, we intend to consider flexible additional returns

boldly and carefully building a foundation for the Group’sbusiness, our balance sheet will expand temporarily, butfrom time to time while taking business trends and market

future growth.

this decision is expected to have significant benefits overenvironments into account.

for growth in recurring revenue business in our medical

on new challenges is necessary for corporate growth, but
the financial department is always on the lookout for risks

Prologuecare business, we will proactively plant the seeds. In “fully

CONTENTS

Accelerate the speed of expansion into a
new Paramount Bed Group

care business remain steady. Because there is still room

Value
Creation
GrowthStrategy

the sellout-style sales when considering medium- andalong with creating new value by utilizing CVC, we will
strengthen our promotion activities in order to increase● Cash Distribution Plan (Cumulative total for FY 2022–2026)

Cash inawareness. Overseas, we are aiming to have the No. 1

factory in order to respond to increasing demand.

EBITDA
From 115 billion yen

Also, last year we disclosed our new cash distribution
right). We plan to allocate cash to growth investments andshareholder returns for the five years through to the fiscal
year ending March 31, 2027. The growth investment inAppropriation of cash on hand
From 10 billion yen

Capital investment
From 15 billion yen

The assets related torecurring revenue
business, CVC
establishment, etc.
From 70 billion yen

Corporate
Data

plan through the final year of Phase II (shown on the

Growth investment

Corporate
Governancemarket share of medical beds in our focus areas of India,
China, and Indonesia. In India we are planning a new

Cash out
Shareholder return
From 20 billion yen
Corporation tax
From 20 billion yen

CapitalStrategy

long-term profitability. In our health promotion business,

32

Integrated Report 2023

Growth Strategy
CONTENTS

Main Services

・ A broad lineup of mattresses to suit diverse needs and bed peripherals such as handrails
・ Medical equipment, ceiling supply units, furniture, and systems used in medical facilities, etc.

(medical equipment manufactured by the Paramount Bed Group and other companies)

Support services within medical facilities as well as patient satisfaction improvement support services

We provide various services to suit on-site needs.

Service examples:）
Bed cleaning, bed making, meal delivery and clearing, tea serving, and hospital equipment inspection, etc.

Maintenance of beds withstationed services

Bed and equipment maintenance, centralized inventory management, etc.

hospital operations. This includes everything

Concierge services

Guiding patients using special hospital rooms to their ward and room, helping with inpatient life, etc.

from general hospital wards, highly acute care

Medical equipment maintenanceand management services

We support patients, medical workers, andfacilities such as emergency and critical care
pediatric care units, and rehabilitation facilities.
Centered on the manufacture and sale ofhospital beds, which is our core business, weCorporate
Governancecenters and ICUs, perinatal, neonatal andMedical equipment collection, cleaning, and inspection; entrusted call center services, repairs, regular inspection
work, or other services for equipment made by medical equipment manufacturers in Japan and abroad

CapitalStrategy

Nursing assistant services

GrowthStrategy

Medical Care
Business

Value
Creation

Repair work and after-sales service

Prologue

Product development, manufacture, sales, and rental
・ Medical beds utilizing sensing technology

are providing a wide range of products andof medical settings in Japan and abroad.

Corporate
Data

services to meet the various on-site demands

33

Integrated Report 2023

Growth Strategy

Key Business Successes and Future Strategy

Japan(Millions of yen)
40,0006,607

33,444

34,230

7,675

7,795

37,291
8,561

39,1199,770

20,00029,33910,00026,43528,7292021/32022/32023/3

75

88

90

40

47

89
41

95
41

Overseas

100
49

50
48

44

47

2020/32021/32022/355

51

2023/32024/3
Forecast

0*Thousands of beds rounded to nearest thousand

workers were promoted in Japan. The recurring revenue

to increase approximately 5% year on year to reach 39,119

business remained strong, including equipment manage-

million yen. The number of beds sold in Japan is planned toment, repair work, nursing assistant services, concierge

decrease by 6% year on year, falling to 51,000. In Japaneseservices, and other on-site services as well as package

medical settings, increasing electricity and labor costs

rentals of equipment and facilities. Also, we offeredcontinue to put pressure on management. We would like toproposals for increased work efficiency using the Smartcontribute toward improved operational conditions and pro-

Bed System™, thereby supporting the promotion of work

motion of work style reforms for medical workers with thestyle reforms. In the fiscal year ended March 31, 2023,

Group’s recurring revenue business, Smart Bed System™,

the system was newly introduced at eight hospitals and isand more. We will further improve and expand our proposal

now in use at a total of 32 hospitals (as of March 2023).

offerings, and strive to expand our businesses, along with

Overseas, results remained mostly steady when based on

solving issues facing medical settings.

local currencies, but increased 10% year on year due toOverseas, the number of beds sold is planned to increase

the effect of exchange rates. In Indonesia, the government

21% year on year to reach 49,000, primarily in large markets

procurement project did meet our expectations, but inincluding China, Indonesia, and India. Along with improving

China our high-functional beds did well. Overall, we set aand expanding our product and service offerings to suit the

new sales record.

needs of various countries, we will also fundamentally revise
our operating strategies for each area.

Corporate
Data

25

In the fiscal year ending March 31, 2024, sales are expected

Corporate
Governance1002024/3
Forecast

Japan(Thousands of beds)

Demand increased as work style reforms for medical

The Smart Bed System™ was introducedin greater numbers.

CapitalStrategy

Number of beds sold

New record high for overseas sales.

Further expansion of recurring
revenue businesses
Promoting wider adoption of
the Smart Bed System™
Increasing number of beds sold in
our focus markets overseas

The recurring revenue businessremained strong.

29,3490

2020/3Future business strategy

GrowthStrategy

25,769Key points fromthe ﬁscal year ended March 31, 2023

Value
Creation

30,00035,946

Overseas

Prologue

Net sales

CONTENTS

Medical Care Business34

Integrated Report 2023

Growth Strategy
CONTENTS

Main Services
Product development, manufacture, sales, andrental wholesale for home care

・ Beds for nursing care facilities
・ Mattresses
・ Care lifts

・ Beds used for home care・ Mattresses
・ Walking aids

・ Monitoring support systems
・ Other tools, furniture, and systems used

at nursing care facilities, etc.

used for home care, etc.

Value
Creation

Sales・ Other assistive products

Rental wholesale
Storage

We develop products and services for nursing
both caregivers and care receivers. For
nursing care facilities, we offer a total range

Sellers
Users

We provide facilities and users with products via
assistive product providers

Maintenance

Assistive products
manufacturers

Disinfection

ReturnAssistive products
rental service
providers

Users

We provide products to assistive products rental service providers, with theGroup also handling shipping, collection, disinfection, maintenance, and storage.

PICK
UP

PICK
UP

operation of facilities, from beds, care lifts,
and bathing facilities to furniture used in livingrooms and dining rooms. For the home care,
we provide assistive products, such as beds
rent them to users through sales and rental
wholesale.

Home care bed “Rakusho Plus Series”

A system that enables remote, real-time observation of residents at nursing

Its rising motion for sitting up combines multiple angles to match thecare facilities. Just place it under the mattress, and you can check whether

body’s movements and helps the user to move more easily. The handheld

the user is asleep, awake, rising, or out of bed, as well as their respiratory

switch can send a call that will be received via smartphone, and the bed

rate, etc. It helps to improve the safety of older people in nursing carecan even be operated using a smartphone. It is also equipped with afacilities and to reduce staff workload during nighttime patrols.

self-inspection function for service providers.

Corporate
Dataand mattresses, to companies that sell or

Monitoring support system “Nemuri SCAN”

Corporate
Governanceof tools and equipment necessary for the

CapitalStrategycare facilities and home care, and support

Shipping

Nursing carefacilities

GrowthStrategy

Nursing Care
Business

Prologue

Product development, manufacture, sales, andrental for nursing care facilities

35

Integrated Report 2023

Growth Strategy
CONTENTS

Nursing Care Business Key Business Successes and Future Strategy(Millions of yen)
60,00036,04937,855

12,59314,0162020/32021/331,598709

1,029

41,89944,202

13,442

14,912

15,4382022/32023/32024/3
Forecast

20,0000

For nursing care facilities, various subsidies were also

eﬀective and there was expanded demand for updating

beds and the “Nemuri SCAN” monitoring system. The total
sales ﬁgures for “Nemuri SCAN” exceeded 150,000 units.

For home care, along with sales for our mainstay “Rakusho

Number of beds sold(Thousands of beds)

100

95
4
51

108
3

66

123
6
77

132
4
84

129
6
81

to sales throughout the year. Our recurring revenue

business of assistive products rental wholesale also demonstrated steady results, and the sales ratio increased. We

also opened two new large-scale maintenance centers forassistive products rental wholesale. Along with promoting
eﬃciency improvement and labor-saving, we also revised
our shipping system, building a system that could quickly

50
38

40

45

42

2020/32021/32022/32023/32024/3
Forecast*Thousands of beds rounded to nearest thousand

yen. Regarding bed sales, while there will be a pause in theincreasing trend observed up until now due mainly to ourmainstay model for home care penetrating the market, we
intend to increase sales by expanding sales of mattresses
and other related peripherals. In wholesale rental ofassistive products, we will improve and expand our original
product offerings. A revenue increase of approximately 7%
is predicted. For nursing care facilities, we will continue focusing on market penetration of “Nemuri SCAN.” “Nemuri
SCAN” has received positive reviews for reducing the workburden on nursing care workers and effectively improving
the safety of facility residents. We aim to promote wider
adoption of “Nemuri SCAN” by improving the support
offered following its implementation and deploying efforts
that lead to increased customer satisfaction.

Corporate
Data

39

meet increasing demand.

ed to increase 6% year on year to reach 60,669 million

Corporate
Governance150“Q-AURA ONE,” launched in March 2022, also contributed

In the fiscal year ending March 31, 2024, sales are expect-

CapitalStrategy

Plus Series” bed continuing to do well, our new product
Facilities in Japan
Homes in Japan
Overseas

Expanding sales for mattresses and otherrelated peripherals
Improving and expanding original
Paramount Care Service products
Focusing on market penetration of“Nemuri SCAN”

GrowthStrategy416

542

57,521

Our mainstay beds were well received
and demand increased for “Nemuri SCAN.”
The recurring revenue business(assistive products rental wholesale)remained strong.
Opened two new large-scale maintenancecenters.

Future business strategy

Value
Creation

52,317
1,018

44,73440,00050,48260,669Key points fromthe ﬁscal year ended March 31, 2023

Prologue

Facilities in Japan
Homes in Japan
Overseas

Net sales

36

Integrated Report 2023

Growth Strategy
CONTENTS

Main Services

・ Automatic electric beds that utilize sleep sensors
・ Electric beds that can transform in the future for nursing-care use

Prologue

Product development, manufacture, and sales for people who do not require medical or nursing care services

・ Membership service supporting comfortable daily life

Health Promotion
Business

The first bed in Japan that detects the status of sleep with sensors andslightly when going to sleep. Next, when the sensors detect that the user is ina sound sleep, the bed slowly flattens to facilitate turning over. This automatic
operation improves sleep quality. And when it is time to wake up, the sensors
detect shallow sleep and raise the back at just the right time to help the user
using a smartphone, which also scores the quality of sleep.

live more healthy lives. We develop and sell

And going forward, we will expand our “sleeptech” services that use technology to solve
sleep problems.

Electric bed “INTIME” that can transform in the future
for nursing-care use
It is conceptualized as “an electric bed that helps throughout a person’s life.”
While it can first be used as a comfortable electric bed, it can transform into a
nursing-care bed in the future if nursing care becomes necessary. It is carefully
This year’s new, fully remodeled “INTIME 1000 Series” comes equipped withconvenient functions such as LED lights that can be used for indirect lighting or
supplemental lighting, and a USB port for charging a smartphone or tablet.

Corporate
Data

designed to blend in with interior furnishings without looking like an electric bed.

Corporate
Governanceof the Paramount Bed Research Institute.

PICK
UP

CapitalStrategy

to awaken more comfortably. These movements can be operated and set

improve daily sleep quality and let people

and pillows that utilize the research results

GrowthStrategy

operates automatically. Breathing becomes easier if you raise the back

We provide products and services that

products such as electric beds, mattresses,

Automatic electric bed “Active Sleep BED” that utilizes
sleep sensors

Value
Creation

PICK
UP

37

Integrated Report 2023

Growth Strategy
CONTENTS

Health Promotion Business Key Business Successes and Future Strategy

Japan

Overseas(Millions of yen)
4,000

0

3,000
2,000
1,000

1,231
0

0

0

1,584

2,141

2,517

Strengthened various promotion activities.

0

3,500

2021/32022/32023/3(Thousands of beds)

0
6

0

0

0
7

9

10

12

the number of customers visiting stores, our “INTIME

ed to increase 39% year on year to reach 3.5 billion yen,

3000,” launched in September 2021, contributed to sales

and beds sold are expected to increase 26% to reachthroughout the year. Despite being in the middle price

12,000 units. Our mainstay model “INTIME 1000” was fully

range within the INTIME Series, it has numerous functions

remodeled in April 2023. It is carefully designed to blend

and an extensive selection of six types of mattresses (otherin even better with interior furnishings without looking liketypes have two to four options), and it has become very

an electric bed. It comes newly equipped with convenient

popular. We also conducted sales promotion support forfunctions such as LED lights that can be used for indirect

dealers with our “Meister System.” Under this system, welighting or supplemental lighting, and a USB port forprovide training in order to help dealers gain knowledge

charging a smartphone or tablet.

and product functions that can be useful when engaging“Sleep tech” has been attracting more attention in recent

with customers. Furthermore, we also strengthened ouryears. Amidst this increasing awareness of sleep, we arepromotion activities in order to increase awareness. As aworking to provide sales promotion support for dealers

result, sales increased 18% year on year.

and to strengthen various promotion activities, as wellas to expand and improve services that enhance user

02020/3In the fiscal year ending March 31, 2024, sales are expect-

2021/32022/32023/3*Thousands of beds rounded to nearest thousand

2024/3
Forecast

satisfaction, thereby expanding our businesses.

Corporate
Data

3

6

7

10

0

Although this was a period when COVID-19 reduced

Corporate
Governance6

Overseas

12992024/3
Forecast

Japan

12

Strengthening various promotion activities
and improving user satisfaction

CapitalStrategy

Number of beds sold

Sales promotion support for dealers

2,517

0

2020/3

Sales promotion support for dealers.

Expanding sales with our fully remodeled
mainstay model

GrowthStrategy

1,231

1,584

2,141

New products contributed to sales
throughout the year.

Future business strategy

Value
Creation

3,500

Key points fromthe ﬁscal year ended March 31, 2023

Prologue

Net sales38

Integrated Report 2023

Growth Strategy

ntʼs

as
Oversesion
Expan

everywhere. Since the establishment of our trading department in 1968, we have been providing services customized to suit the needsof various countries. Our products have been delivered to 110 or more countries worldwide. Currently, aiming toward localization,

we have locations in Southeast Asia, including Indonesia, China, India, and other countries. We have also established a regional HQ

company Paramount Bed Asia Paciﬁc Pte. Ltd. in Singapore, and are focusing on the Asian region as a promising market predicted tohave particularly increasing needs in the future.

110

Paramount Bed (China)
Co., Ltd.

or more countries

Production sites

Paramount Bed Mexico
S.A. de C.V.

PARAMOUNT BED
ASIA PACIFIC PTE.LTD.

PARAMOUNT BED(THAILAND)CO.,LTD.

Corporate
Data

PT. Paramount Bed
Indonesia

Corporate
Governance

PARAMOUNT BED VIETNAM CO.,LTD.
PARAMOUNT BED VIETNAM TRADING CO.,LTD.

CapitalStrategy

10
4 factories

overseas
locations

PARAMOUNT BED
INDIA Private Limited.

Delivery record in

GrowthStrategyOverseas Group companies

PARAMOUNT BED
USA Corporation.

Value
Creation

Shanghai Representative Ofﬁce

Prologueou
Param

CONTENTS

We want to support the medical and nursing care industries, not only in Japan but around the world, as well as the health of people

39Integrated Report 2023

Growth Strategy
CONTENTS

Consolidated Overseas Net Sales
Consolidated overseas net sales
Overseas sales ratio

Aiming to be the top

10,000

8,813

9,000

China, Indonesia, and India are countries where the population is large, the number of hospital beds is expected toincrease, and an increased demand for high-functional beds such as electric beds is anticipated. We consider thesecountries as priority areas for overseas expansion, and we have been taking actions there for many years. As a result,

9.4

11

10.3

7

7,000

3

0

0

2022/3are still currently used in China. We hope to steadily respond to a demand for updating the beds to electric beds there

2023/32024/3
Forecast

GrowthStrategy

we hold a top-class market share in electric beds there in particular. On the other hand, large numbers of manual beds

9.8

8,000

15

9,271

in the future. Also, over ten years have passed since we moved into India. In order to meet the expanding demand there,
we will begin operating a new large-scale factory in India in FY 2024 and work to improve our production capability. We
plan to further strengthen our initiatives for priority areas such as these, and aim to be the top medical bed manufacturer

Consolidated Overseas Net Sales by Region(Millions of yen)2024/3
Forecast

7,923

8,174

9,897

− Indonesia

2,772

2,874

3,657

− China

2,803

3,029

3,524

Asian
− Othercountries

2,346

2,269

2,715

68

222

235

227

505

526

595

369

140

Asia

Middle East

Central andSouth America
Other

Corporate
Data

2023/3

Corporate
Governance2022/3

CapitalStrategyin Asia. Furthermore, we will gradually start working in other bed-related areas just as we have in Japan.

Medical electric bed for India, “Qualitas Nx Series”

Value
Creation

medical bed manufacturer in Asia.

（％）
19

10,80011,000

Prologue(Millions of yen)